A study of IFN Kinoid for Type 1 Diabetes.
Phase of Trial: Phase II
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Interferon alpha kinoid (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 31 Jan 2017 New trial record
- 25 Jan 2017 According to a Neovacs media release, company is planning to initiate this clinical program in the first half of 2018.